3BLOOMGARDEN ZT. Inflammation and insulin resistance[J].Diabetes Care,2003,26(8) :1619-1623.
4Freeman DJ,Norrie J,Caslake MJ,et al. C reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland Coronary Prevention Study [J]. Diabetes, 2002,51 (5) :1596-1600.
5Freeman DJ ,Norrie J ,Sattar N,et al. Pravastatin and the development ofdiabetes mellitus: evidence for a protective treatment effect in the west of Scotland Coronary Prevention Study[J]. Circulation, 2001,103 (3) : 362-375.
6Festa AD, Agostion R Jr, Howard G. Chronic subclinical inflammation as part of the insulin Resistance syndrome: the Insulin Resistance Atheroselerosis Study (IRSA)[J]. Circulation, 2000, 120(1):42-47.
3Montalescot G,Ankri A,Chadefanx VB,et al.Plasmahomocysteine and the extent of atherosclerosis in patients with coronarydisease[J].Int J Cardiol,1997,(60):295.
4Reece EA,Homke C,Wizntzer A.Metabolic changes in diabetic and mondiabetic subjects durny pregnancy[J].Obstet Gynecol Surv,1994,49(1):64-71.
5曹泽毅.中华妇产科学[M].北京：人民卫生出版社,1999.2129.
6Van Guldener C.Homocysteine lowing trialists collab- oration. Lowingblood homocysteine with folic acid based supplements: Meta-analysisof randomized trials[J].BMJ,2009,316(6):893.
7Wang X.Homoeysteine upregulates resistin production from Adip- ocytes in vivo and in vivo [J].Diabets,2008,57(4):817.
8Pradhan AD,Manson JE,Rifai N. C-reactive protein,interleukin 6,and risk of developing type 2 diabetes mellitus[J].{H}JAMA:the Journal of the American Medical Association,2001,(03):327-334.
9Bacha F,Saad R,Gungor N. Adiponectin in youth:relationship to visceral adiposity,insulin sensitivity,and beta-cell function[J].{H}DIABETES CARE,2004,(02):547-552.
10Festa A,D'Agostino R Jr,Tracy RP. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes:the insulin resistance atherosclerosis study[J].{H}DIABETES,2002,(04):1131-1137.
